Topic
How to give naloxone
💡 What You Need to Know
- Life-Saving Medication: Naloxone is an opioid antagonist that can rapidly reverse the effects of an opioid overdose.
- Emergency Use: Administer naloxone immediately if you suspect an opioid overdose, characterized by severe respiratory depression or unconsciousness.
- Safety Profile: It is safe to administer naloxone even if the person is not experiencing an opioid overdose; it will not cause harm.
- Accessibility: Naloxone is available without a prescription in many areas and should be carried by individuals at risk or those who may encounter someone at risk.
🤒 Associated Symptoms
- Slow or Stopped Breathing: Respiration becomes very slow, shallow, or ceases entirely.
- Unresponsiveness: The person cannot be woken up, even with sternal rub or loud shouting.
- Pinpoint Pupils: Pupils may be extremely small, like pinpoints, though this can vary.
- Blue/Gray Skin or Lips: Cyanosis, particularly around the lips and fingertips, indicates lack of oxygen.
- Gurgling or Choking Sounds: These sounds may indicate airway obstruction or fluid in the lungs.
- Limp Body: The person's body may be very relaxed and unresponsive.
🛡 Crucial Precautions
- Call Emergency Services: Always call 911 (or your local emergency number) immediately before or after administering naloxone, as its effects are temporary.
- Stay with the Individual: Do not leave the person alone, as they may require additional doses or further medical intervention.
- Administer Rapidly: Time is critical in an overdose; administer naloxone as quickly as possible once an overdose is suspected.
- Monitor for Withdrawal: Be prepared for potential acute opioid withdrawal symptoms, which can include agitation, vomiting, and muscle cramps.
- Recovery Position: If the person regains consciousness and is breathing, place them in the recovery position to prevent aspiration if vomiting occurs.
🍽 Dietary Directions & Restrictions
- Aspiration Risk: If the person is unconscious or semi-conscious, do not attempt to give them any food or fluids by mouth due to severe aspiration risk.
- Post-Administration Monitoring: After naloxone administration and regaining consciousness, monitor closely for nausea and vomiting, which are common withdrawal symptoms.
- Hydration Post-Recovery: Once fully conscious and able to swallow safely, offer small sips of water or clear fluids, monitoring for tolerance.
- No Oral Intake During Overdose: Absolutely no oral intake of food or drink should be given to an individual experiencing an active opioid overdose.
⚠️ Attendant Guidelines
- Continuous Monitoring: Continuously monitor the person's breathing, responsiveness, and skin color until emergency medical personnel arrive.
- Multiple Doses: Be prepared to administer additional doses of naloxone every 2-3 minutes if the person does not respond or if breathing remains shallow.
- Temporary Effect: Naloxone's effects are temporary (typically 30-90 minutes); the opioid may last longer, leading to re-sedation.
- Potential for Agitation: The person may wake up confused, agitated, or combative due to sudden withdrawal; ensure your safety and their safety.
- Do Not Assume Full Recovery: Even if the person appears to recover, they still need professional medical evaluation and care.
🩺 Physician's Perspective
- Timely Intervention: Emphasize that rapid administration of naloxone is paramount in preventing anoxic brain injury and death from opioid overdose.
- Comprehensive Care: Naloxone is an emergency intervention; it does not replace the need for comprehensive medical evaluation and ongoing support for opioid use disorder.
- Patient Education: Physicians should educate patients at risk and their families about overdose recognition, naloxone administration, and harm reduction strategies.
- Prescription & Access: Advocate for increased access to naloxone through standing orders and co-prescription for patients on high-dose opioids or with a history of overdose.
- Follow-up Care: Stress the importance of connecting individuals who have experienced an overdose with appropriate addiction treatment and support services.
🎓 Academic & Nursing Corner
- Mechanism of Action: Naloxone is a competitive opioid receptor antagonist, binding to mu, kappa, and delta opioid receptors, reversing opioid effects.
- Pharmacokinetics: Rapid onset (2-5 minutes intranasal, 1-2 minutes IM/IV), but a short half-life (30-90 minutes), necessitating close monitoring for re-sedation.
- Assessment Skills: Focus on rapid assessment of airway, breathing, circulation (ABCs), pupil response, and level of consciousness using tools like the Glasgow Coma Scale.
- Post-Administration Care: Monitor vital signs, oxygen saturation, respiratory effort, and neurological status; manage acute withdrawal symptoms.
- Patient & Family Education: Provide clear instructions on overdose prevention, safe medication storage, and the importance of seeking ongoing treatment.
🔬 Clinical Reference Index
- Dosage (Adult): Typically 0.4 mg to 2 mg intramuscular (IM) or intravenous (IV), or 2 mg to 4 mg intranasal (IN) per dose. Higher doses may be required for synthetic opioids.
- Routes of Administration: Intranasal (nasal spray), Intramuscular (auto-injector or syringe), Intravenous (hospital setting), Subcutaneous.
- Onset of Action: Intravenous: 1-2 minutes; Intramuscular: 2-5 minutes; Intranasal: 2-5 minutes.
- Duration of Action: Approximately 30-90 minutes, which is often shorter than the duration of action of many opioids.
- Adverse Effects: Primarily symptoms of acute opioid withdrawal (nausea, vomiting, diarrhea, muscle aches, agitation, tachycardia, hypertension).
- Storage: Store at room temperature, away from light and extreme temperatures. Check expiration dates regularly.